Development of an Enzyme-Linked Immunosorbent Assay and Immunoaffinity Column Chromatography for Saikosaponin d Using an Anti-Saikosaponin d Monoclonal Antibody

Abstract

This work developed a novel immunochemical approach for the quality control of saikosaponin d using an enzyme-linked immunosorbent assay. Splenocytes from mice immunized with the saikosaponin d-bovine serum albumin conjugate were fused with the hypoxanthine-aminopterin-thymidine-sensitive mouse myeloma SP2/0 cell line, and a hybridoma secreting monoclonal antibody against saikosaponin d was successfully obtained. The prepared anti-saikosaponin d monoclonal antibody 1E7F3 has a novel characteristic, showing weak reactivity with compounds that are structurally related to saikosaponin d. Using monoclonal antibody 1E7F3, a specific and reliable enzyme-linked immunosorbent assay was developed to detect saikosaponin d. The system shows a full measurement range from 156.25 to 5000.00 ng × mL⁻¹. Both intra-assay and inter-assay repeatability and precision were achieved, with relative standard deviations lower than 10.00 %. The recovery rates ranged from 92.36 % to 101.00 %, meeting the requirements for biological samples. There was a good correlation between the enzyme-linked immunosorbent assay and high-performance liquid chromatography analyses of saikosaponin d, and the saikosaponin d levels in formulated Chinese medicines were successfully determined. Furthermore, immunoaffinity column chromatography was established using this anti-saikosaponin d monoclonal antibody, and the elution profile of saikosaponin d was detected by a Bio-Rad QuadTec UV/Vis detector at 203 nm. The results demonstrate that we generated a reliable and more efficient assay system for measuring saikosaponin d and provide a potential approach for purifying and separating saikosaponin d.

Key words

Bupleurum - Apiaceae - Bupleuri radix - saikosaponin d - monoclonal antibody - ELISA - immunoaffinity column chromatography

• References

• 1 Pharmacopoeia Commission of China. Pharmacopoeia of Peopleʼs Republic of China. Beijing: China Medical Science Press; 2010: 263
• 2 Zhu J, Luo CQ, Wang P, He QY, Zhou JD, Peng H. Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. Exp Ther Med 2013; 5: 1345-1350
• 3 Tsai YJ, Chen IL, Horng LY, Wu RT. Induction of differentiation in rat C6 glioma cells with saikosaponins. Phytother Res 2002; 16: 117-121
• 4 Cheng PW, Chiang LC, Yen MH, Lin CC. Bupleurum kaoi inhibits coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. Food Chem Toxicol 2007; 45: 24-31
• 5 Cheng YL, Chang WL, Lee SC, Liu YG, Chen CJ, Yu DS, Lin SZ, Harn HJ. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci 2003; 73: 2383-2394
• 6 Zhao RZ, Liu LJ, Wang YJ, Xiao ZC. Vinegar-baked Radix Bupleuri modulates the cell membrane constituents and inhibits the P-gp activity in rat hepatocytes. BMC Complement Altern Med 2014; 14: 357
• 7 Ashour ML, Wink M. Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action. J Pharm Pharmacol 2011; 63: 305-321
• 8 Bai YJ, Zhao YY, Tan L, Zhang RY. Study on the chemical constituents of the roots from Bupleurum scorzonerifolium . J Pharm Sci 1999; 8: 105-107
• 9 Wu GC, Wu H, Fan LY, Pan HF. Saikosaponins: a potential treatment option for systemic lupus erythematosus. Ir J Med Sci 2011; 180: 259-261
• 10 Sui C, Zhang J, Wei J, Chen S, Li Y, Xu J, Jin Y, Xie C, Gao Z, Chen H, Yang C, Zhang Z, Xu Y. Transcriptome analysis of Bupleurum chinense focusing on genes involved in the biosynthesis of saikosaponins. BMC Genomics 2011; 12: 539
• 11 Liu Y, Cao C, Ding H. Pharmacological experimental study of the anti-depressant effect of total saikosaponins. Afr J Tradit Complement Altern Med 2014; 11: 280-284
• 12 Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ, Liao M, Chen JX. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway. Int Immunopharmacol 2012; 14: 121-126
• 13 Hattori T, Nishimura H, Kase Y, Takeda S. Saireito and saikosaponin D prevent urinary protein excretion via glucocorticoid receptor in adrenalectomized WKY rats with heterologous-phase anti-GBM nephritis. Nephron Physiol 2008; 109: 19-27
• 14 Fan J, Li X, Li P, Li N, Wang T, Shen H, Siow Y, Choy P, Gong Y. Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury. Biochem Cell Biol 2007; 85: 189-195
• 15 Dang SS, Wang BF, Cheng YA, Song P, Liu ZG, Li ZF. Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats. World J Gastroenterol 2007; 13: 557-563
• 16 Shyu KG, Tsai SC, Wang BW, Liu YC, Lee CC. Saikosaponin C induces endothelial cells growth, migration and capillary tube formation. Life Sci 2004; 76: 813-826
• 17 Wang Q, Zheng XL, Yang L, Shi F, Gao LB, Zhong YJ, Sun H, He F, Lin Y, Wang X. Reactive oxygen species-mediated apoptosis contributes to chemosensiti- zation effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res 2010; 29: 159
• 18 Liu RY, Li JP. Saikosaponin-d inhibits proliferation of humanundifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest. Eur Rev Med Pharmacol Sci 2014; 18: 2435-2443
• 19 Li ZY, Sun HM, Xing J, Qin XM, Du GH. Chemical and biological comparison of raw and vinegar-baked Radix Bupleuri. J Ethnopharmacol 2015; 165: 20-28
• 20 Tian RT, Xie PS, Liu HP. Evaluation of traditional Chinese herbal medicine: Chaihu (Bupleuri Radix) by both high-performance liquid chromatographic and high-performance thin-layer chromatographic fingerprint and chemometric analysis. J Chromatogr A 2009; 1216: 2150-2155
• 21 Zhou Y, Lin Y, Liu X, Ju W. Simultaneous determination of 12 index components and compatibility changes in Longchai decoction by liquid chromatography-mass spectrometry. J Chromatogr Sci 2015; 53: 60-65
• 22 Zhu S, Shimokawa S, Shoyama Y, Tanaka H. A novel analytical ELISA-based methodology for pharmacologically active saikosaponins. Fitoterapia 2006; 77: 100-108
• 23 Zhu SH, Shimokawa S, Tanaka H, Shoyama Y. Development of an assay system for saikosaponin a using antisaikosaponin a monoclonal antibodies. Biol Pharm Bull 2004; 27: 66-71
• 24 Lu ZH, Morinaga O, Tanaka H, Shoyama Y. A quantitative ELISA using monoclonal antibody to survey paeoniflorin and albiflorin in crude drugs and traditional Chinese herbal medicines. Biol Pharm Bull 2003; 26: 862-866
• 25 Qu H, Wang Y, Shan WC, Zhang Y, Feng H, Sai J, Wang Q, Zhao Y. Development of ELISA for detection of Rh1 and Rg2 and potential method of immunoaffinity chromatography for separation of epimers. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 985: 197-205
• 26 Qu H, Zhang G, Li Y, Sun H, Sun Y, Zhao Y, Wang Q. Development of an enzyme-linked immunosorbent assay based on anti-puerarin monoclonal antibody and its applications. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 953–954: 120-125
• 27 Fukuda N, Tanaka H, Shoyama Y. Isolation of the pharmacologically active saponin ginsenoside Rb1 from ginseng by immunoaffinity column chromatography. J Nat Prod 2000; 63: 283-285
• 28 Aref NE, Saeed AM. Generation of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coli . Vaccine 2012; 30: 6341-6346
• 29 Ishiyama M, Shoyama Y, Murakami H, Shinohara H. Production of monoclonal antibodies and development of an ELISA for solamargine. Cytotechnology 1996; 18: 153-158
• 30 Schreck RR, Warburton D, Miller OJ, Beiser SM, Erlanger BF. Chromosome structure as revealed by a combined chemical and immunochemical procedure. Proc Natl Acad Sci U S A 1973; 70: 804-807
• 31 Qu H, Sai J, Wang Y, Sun Y, Zhang Y, Li Y, Zhao Y, Wang Q. Establishment of an enzyme-linked immunosorbent assay and application on determination of ginsenoside Re in human saliva. Planta Med 2014; 80: 1143-1150
• 32 Darwish IA, Al-Obaid AM, Al-Malaq HA. New highly sensitive enzyme immunoassay for determination of pravastatin in human plasma. Talanta 2009; 79: 1478-1483
• 33 Darwish IA, Alzoman NZ, Abuhejail RM, EI-Samani TE. Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma. Chem Cent J 2012; 6: 125
• 34 Galfre G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981; 73: 3-46
• 35 North SM, Styles JM, Hobbs SM, Dean CJ. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production. Immunology 1982; 47: 397-405
• 36 Johnson DR. Murine monoclonal antibody development. Methods Mol Biol 1995; 51: 123-137
• 37 Liu HF, Ma J, Winter C, Bayer R. Recovery and purification process development for monoclonal antibody production. MAbs 2010; 2: 480-499
• 38 Zhang Y, Qu H, Zeng W, Zhao Y, Shan W, Wang X, Wang Q, Zhao Y. Development of an enzyme-linked immunosorbent assay and immunoaffinity chromatography for glycyrrhizic acid using an anti-glycyrrhizic acid monoclonal antibody. J Sep Sci 2015; 38: 2363-2370
• 39 Weiler EW, Zenk MH. Radioimmunoassay for determination of digoxin and related compounds in Digitalis lanata . Phytochemistry 1976; 15: 1537-1545